Hourly Briefing · Oct 28, 2026 · 12:09 PM ET

Infiniti Intelligence Hourly Briefing — Oct 28, 2026 · 12:09 PM ET

2 stories in this edition: 2 Fed rate hikes happen in 2026 priced at 80.0% on Polymarket, up 4.5 points, on $208K traded · FDA approves Retatrutide this year priced at 3.2% on Polymarket, up 1.1 points, on $596K traded

2 Fed rate hikes happen in 2026 priced at 80.0% on Polymarket, up 4.5 points, on $208K traded

PredictionBubbles' movers board, on its Oct. 28, 15:09 UTC read, lists the two-hikes contract among its upward finance moves, in a finance category distinct from the…

The Polymarket contract on two Federal Reserve rate hikes in 2026 was priced at 80.0%, up 4.5 probability points, with $208K traded, according to the supplied market update. PredictionBubbles’ Oct. 28, 15:09 UTC movers-board reading placed the contract among rising finance markets.

A shift in pricing, not a policy signal

The increase reflects a change in traders’ pricing over 24 hours. It does not establish that the Federal Reserve’s policy outlook changed for any particular reason: the supplied material identifies no announcement or other catalyst behind the move.

According to PredictionBubbles, its rankings measure changes in probability points rather than relative percentages. Trading volume provides context but does not affect a market’s position in the movement rankings.

Snapshot timing matters

The supplied PredictionBubbles page carries a later timestamp of 28 Oct 2026, 16:10 UTC, rather than the 15:09 UTC reading cited in the summary. Its extracted text explains the board’s methodology but does not reproduce the two-hikes contract’s price-and-volume entry, so it does not independently confirm those figures at the later timestamp.

PredictionBubbles says it refreshes venue-sourced prices every 15 minutes and covers both Polymarket and Kalshi. The supplied page ranks 2,003 markets lasting longer than 14 days, with only open markets that have a valid 24-hour price comparison eligible for inclusion.

What it means for prediction markets

80.0% is a market-implied probability, not confirmation that two hikes will occur in 2026.
The 4.5-point rise describes the size of the repricing; the supplied reporting does not explain its cause.
$208K traded adds activity context, but the material does not establish the contract’s order-book depth.
The figures belong to a particular snapshot. The later page timestamp should not be treated as verification of an unchanged price.

Predictionbubbles (predictionbubbles.net)https://predictionbubbles.net/markets/movers/

FDA approves Retatrutide this year priced at 3.2% on Polymarket, up 1.1 points, on $596K traded

No significant new platform headline in the last 30 minutes; news search recirculated only items already used today, taken by website-only batches, or on the banned list…

Polymarket traders priced FDA approval of Retatrutide this year at 3.2%, up 1.1 percentage points, in the supplied market snapshot published Oct 28, 2026 · 12:09 PM ET. Total traded volume stood at $596K. The price reflects expectations about approval, not an announcement that approval has occurred.

A higher price, but a low implied probability

The move leaves approval this year a low-probability outcome in the market’s pricing. The increase is measured in percentage points, rather than as a percentage return.

The accompanying news-search summary identified no significant new platform headline in the preceding 30 minutes. The supplied material therefore does not establish a fresh news catalyst for the price change or provide a regulatory update explaining it.

Reading the snapshot

According to predictionbubbles.net, its market data refreshes every 15 minutes, and its movement figures measure probability changes over the preceding 24 hours. The site defines traded volume as total activity where the venue publishes it; the $596K figure should not be read as money traded during the latest move.

PredictionBubbles says it displays prices from Polymarket and Kalshi, where trading is continuous. Its supplied page explains those data conventions but does not include the Retatrutide contract’s wording or resolution criteria, limiting what can be concluded beyond the headline snapshot.

What it means for prediction markets

Direction and level differ: the probability rose 1.1 percentage points, but the 3.2% price still indicates a low market-implied likelihood of approval this year.
The catalyst is unconfirmed: the supplied reporting does not connect the repricing to a new FDA development.
Volume is not timing: $596K represents total traded volume, not evidence of a recent burst of trading.
Contract details remain important: without the exact wording and resolution rules, the supplied material cannot establish precisely what would qualify as an approval outcome.

Predictionbubbles (predictionbubbles.net)https://predictionbubbles.net/markets/tech/

Full attribution under the DMCA, 17 U.S.C. § 512: original Infiniti Intelligence reports summarizing and linking to the publishers named above. All rights in the underlying reporting remain with them.